|
ARIH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.987700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.450500E-02 |
| Normal-vs-Stage2 |
1.826230E-01 |
| Normal-vs-Stage3 |
6.76380000008692E-07 |
| Normal-vs-Stage4 |
1.93219999999883E-05 |
| Stage1-vs-Stage2 |
8.292000E-01 |
| Stage1-vs-Stage3 |
8.09010000000221E-05 |
| Stage1-vs-Stage4 |
6.802700E-04 |
| Stage2-vs-Stage3 |
3.940000E-02 |
| Stage2-vs-Stage4 |
4.366200E-02 |
| Stage3-vs-Stage4 |
9.994200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.384200E-04 |
| Normal-vs-AfricanAmerican |
3.560800E-04 |
| Normal-vs-Asian |
8.504600E-01 |
| Caucasian-vs-AfricanAmerican |
2.022000E-01 |
| Caucasian-vs-Asian |
2.378400E-01 |
| AfricanAmerican-vs-Asian |
9.599600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.88590000000422E-05 |
| Normal-vs-Female |
1.919710E-02 |
| Male-vs-Female |
8.457800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.207900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.440370E-02 |
| Normal-vs-Age(61-80Yrs) |
1.227790E-04 |
| Normal-vs-Age(81-100Yrs) |
9.400500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.716200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.360200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.010200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.717700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.752000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.596400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.553000E-01 |
| Normal-vs-Grade 2 |
1.421790E-01 |
| Normal-vs-Grade 3 |
1.77120999999003E-05 |
| Normal-vs-Grade 4 |
3.84120000029853E-07 |
| Grade 1-vs-Grade 2 |
1.749360E-01 |
| Grade 1-vs-Grade 3 |
3.621300E-03 |
| Grade 1-vs-Grade 4 |
8.159900E-04 |
| Grade 2-vs-Grade 3 |
9.7589000000009E-05 |
| Grade 2-vs-Grade 4 |
2.42839999999855E-05 |
| Grade 3-vs-Grade 4 |
1.199160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.832200E-01 |
| Normal-vs-ccB subtype |
8.635100E-04 |
| ccA subtype-vs-ccB subtype |
5.359400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.023500E-03 |
| Normal-vs-N1 |
8.300000E-02 |
| N0-vs-N1 |
3.315600E-01 |
|
|
